Recently, our CSO Dr. Ya-Chi Chen was featured in an interview with Bioconjugate Insights, where she shared OBI’s approach to next-generation ADC design.

Read more:
obipharma.com/news/bioconj...

#BispecificAntibodies #DualPayloadADC
#ADC #CancerResistance #NextGenADC

OBI Pharma showcased its next-gen #ADC strategies at #2025WorldADCAsia with 3 talks, 1 panel & 3 posters!
#OBIPharma #NextGenADC #Oncology #DualPayload #TargetedTherapy #WorldADCEventSeries

www.obipharma.com/news/2025-wo...